<DOC>
	<DOC>NCT00551616</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.</brief_summary>
	<brief_title>Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>women 16 or older in UK(except Northern Ireland) sites, 17 years or more in Northern Ireland (UK) and 18 years or more in Ireland and US present within 120 hours of unprotected intercourse regular menstrual cycles No current use of hormonal contraception Willing to not use hormonal methods of contraception until study completion At least one complete menstrual cycle (2 menses) post miscarriage, delivery or abortion For women who present more than 72 hours after intercourse, decline the insertion of an IUD for emergency contraception Able to provide informed consent Willing to abstain from further acts of unprotected intercourse until study completion One or more acts of unprotected intercourse more than 120 hours current or recent use of hormonal methods of contraception currently pregnant or breastfeeding tubal ligation or current use of IUD Use of hormonal emergency contraception since last menstrual period Current use of IUD Tubal ligation Partner with a vasectomy Unsure about the date of the last menstrual period Severe asthma insufficiently controlled by oral glucocorticoid Hypersensitivity to the active substance levonorgestrel or any of the excipients of the drug products used in the study</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>